BR9714066A - Processo para a preparação de derivados de tiazol. - Google Patents

Processo para a preparação de derivados de tiazol.

Info

Publication number
BR9714066A
BR9714066A BR9714066-0A BR9714066A BR9714066A BR 9714066 A BR9714066 A BR 9714066A BR 9714066 A BR9714066 A BR 9714066A BR 9714066 A BR9714066 A BR 9714066A
Authority
BR
Brazil
Prior art keywords
compound
formula
preparation
converting
thiazole derivatives
Prior art date
Application number
BR9714066-0A
Other languages
English (en)
Other versions
BR9714066B1 (pt
Inventor
Thomas Pitterna
Henry Szczepanski
Peter Maienfisch
Ottmar Franz Hueterf
Thomas Rapold
Marcel Senn
Thomas Goebel
Anthony Cornelius O'sullivan
Gottfried Seifert
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9714066A publication Critical patent/BR9714066A/pt
Publication of BR9714066B1 publication Critical patent/BR9714066B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Eyeglasses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Patente de Invenção: <B>"PROCESSO PARA A PREPARAçãO DE DERIVADOS DE TIAZOL"<D>. A invenção refere-se a um processo para a preparação de um composto da fórmula em que Q, Y, Z, R1, R2, R3, R4 e R5 são conforme definido na especificação, o que compreende a) reação de um composto da fórmula com um composto halogenante para formar um composto da fórmula ou b) conversão de um composto de fórmula (II) por meio de um agente halogenante em um composto da fórmula; opcionalmente c) conversão do composto de fórmula (IV) em um composto da fórmula (III); d) conversão de um composto de fórmula (III) por meio de um composto da fórmula (V) em um composto da fórmula ou e) conversão de um composto (IV) por meio de um composto (V) em um composto (VI); e f) conversão de um composto (VI) por meio de um agente de cloração em composto (I); um composto (IV); a um processo para a preparação de um composto (III) e a um processo para a preparação de um composto (IV).
BRPI9714066-0A 1996-12-19 1997-12-17 processo para a preparaÇço de derivados de tiazol, bem como intermediÁrios e processos para sua preparaÇço. BR9714066B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH312496 1996-12-19
PCT/EP1997/007087 WO1998027074A1 (en) 1996-12-19 1997-12-17 Process for the preparation of thiazole derivatives

Publications (2)

Publication Number Publication Date
BR9714066A true BR9714066A (pt) 2000-05-09
BR9714066B1 BR9714066B1 (pt) 2009-01-13

Family

ID=4249128

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9714066-0A BR9714066B1 (pt) 1996-12-19 1997-12-17 processo para a preparaÇço de derivados de tiazol, bem como intermediÁrios e processos para sua preparaÇço.

Country Status (24)

Country Link
US (3) US6121455A (pt)
EP (1) EP0946531B1 (pt)
JP (1) JP4275742B2 (pt)
KR (1) KR100525937B1 (pt)
CN (2) CN1086388C (pt)
AR (1) AR008539A1 (pt)
AT (1) ATE308531T1 (pt)
AU (1) AU727669B2 (pt)
BR (1) BR9714066B1 (pt)
CA (1) CA2274177C (pt)
CZ (1) CZ296558B6 (pt)
DE (1) DE69734526T2 (pt)
DK (1) DK0946531T3 (pt)
ES (1) ES2251747T3 (pt)
HU (1) HU225458B1 (pt)
ID (1) ID22398A (pt)
IL (1) IL130298A (pt)
IN (1) IN2012DE00109A (pt)
PL (1) PL196029B1 (pt)
RU (1) RU2191775C2 (pt)
TW (1) TW432056B (pt)
UA (1) UA54473C2 (pt)
WO (1) WO1998027074A1 (pt)
ZA (1) ZA9711358B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU727669B2 (en) * 1996-12-19 2000-12-21 Syngenta Participations Ag Process for the preparation of thiazole derivatives
UA76708C2 (uk) * 1999-12-08 2006-09-15 Сінгента Патисипейшонс Аг Антитіло, яке застосовується в імунологічному аналізі зразка для визначення неонікотиноїдного інсектициду, білковий кон'югат для одержання антитіла, спосіб визначення концентрації неонікотиноїдного інсектициду в зразку та набір для визначення кількості неонікотиноїдного інсектициду
TWI359810B (en) * 2004-11-04 2012-03-11 Mitsubishi Tanabe Pharma Corp Carboxylic acid derivative containing thiazole rin
CN102177999B (zh) * 2011-04-03 2015-08-26 普洱市思茅区梆尔茶业有限公司 一种保健茶粉及其加工工艺和用途
CN103242258A (zh) * 2013-05-13 2013-08-14 南京工业大学 一种噻虫胺合成工艺
JP6643763B2 (ja) * 2014-02-03 2020-02-12 国立大学法人 東京大学 アゾール誘導体骨格を有するペプチドの製造方法
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
WO2022200364A1 (en) 2021-03-25 2022-09-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
BR112023023856A2 (pt) 2021-05-14 2024-01-30 Syngenta Crop Protection Ag Controle de pragas de insetos, ácaros e nematódeos
CN117320551A (zh) 2021-05-14 2023-12-29 先正达农作物保护股份公司 种子处理组合物
WO2022268813A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2022268815A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105064A1 (en) 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105065A1 (en) 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712307A1 (de) * 1987-04-10 1988-10-20 Bayer Ag 3-substituierte 1-(2-chlor-thiazol-5-yl-methyl)-2- nitroimino-1,3-diazacycloalkane
IE960441L (en) * 1988-12-27 1990-06-27 Takeda Chemical Industries Ltd Guanidine derivatives, their production and insecticides
IL99161A (en) * 1990-08-17 1996-11-14 Takeda Chemical Industries Ltd History of guanidine A process for their preparation and preparations from pesticides that contain them
TW198724B (pt) * 1990-10-24 1993-01-21 Ciba Geigy Ag
WO1997010226A1 (en) * 1995-09-11 1997-03-20 Novartis Ag Process for preparing a 2-chloro-5-chloromethyl-thiazole compound
ZA9610046B (en) * 1995-12-01 1997-07-10 Ciba Geigy Process for preparing 2-chlorothiazole compounds
ES2224187T3 (es) * 1995-12-21 2005-03-01 Syngenta Participations Ag Procedimiento para la preparacion de 2-cloro-5-clorometiltiazol.
AU727669B2 (en) * 1996-12-19 2000-12-21 Syngenta Participations Ag Process for the preparation of thiazole derivatives

Also Published As

Publication number Publication date
CN1086388C (zh) 2002-06-19
CN1397552A (zh) 2003-02-19
ID22398A (id) 1999-10-07
CZ296558B6 (cs) 2006-04-12
TW432056B (en) 2001-05-01
CZ219599A3 (cs) 1999-09-15
HUP0000524A2 (hu) 2000-06-28
CA2274177C (en) 2007-09-18
CN1196688C (zh) 2005-04-13
UA54473C2 (uk) 2003-03-17
EP0946531A1 (en) 1999-10-06
JP4275742B2 (ja) 2009-06-10
US6369233B1 (en) 2002-04-09
DK0946531T3 (da) 2006-02-13
PL333925A1 (en) 2000-01-31
BR9714066B1 (pt) 2009-01-13
CN1241182A (zh) 2000-01-12
JP2001506254A (ja) 2001-05-15
DE69734526D1 (de) 2005-12-08
AU727669B2 (en) 2000-12-21
US6121455A (en) 2000-09-19
AR008539A1 (es) 2000-01-19
ZA9711358B (en) 1998-07-08
HUP0000524A3 (en) 2001-02-28
WO1998027074A1 (en) 1998-06-25
RU2191775C2 (ru) 2002-10-27
CA2274177A1 (en) 1998-06-25
ATE308531T1 (de) 2005-11-15
EP0946531B1 (en) 2005-11-02
IL130298A (en) 2004-03-28
AU5759298A (en) 1998-07-15
HU225458B1 (en) 2006-12-28
DE69734526T2 (de) 2006-07-13
KR100525937B1 (ko) 2005-11-08
US20030065191A1 (en) 2003-04-03
IL130298A0 (en) 2000-06-01
ES2251747T3 (es) 2006-05-01
PL196029B1 (pl) 2007-11-30
KR20000069615A (ko) 2000-11-25
IN2012DE00109A (pt) 2015-05-08
US6677457B2 (en) 2004-01-13

Similar Documents

Publication Publication Date Title
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
CO5210911A1 (es) Trifluorbutenos nematicidas
CO4820391A1 (es) Compuestos hipolipidemicos de benzotiazepina
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
FI955885A0 (fi) Vesipohjaiset organopolysiloksaanipitoiset koostumukset, niiden valmistusmenetelmä ja käyttö
FI955884A0 (fi) Vesipohjaiset organopolysiloksaanipitoiset koostumukset, niiden valmistusmenetelmä ja käyttö
ZA948078B (en) Inclusion complex.
FR2515179B1 (pt)
BR9106518A (pt) Preparacao de piperidinas substituidas
EP1077218A3 (en) Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
ATE280767T1 (de) Antidiabetische thiazolidindione und ihre herstellung
BR9901378A (pt) Processo de purificação de uma solução aquosa em relação a compostos orgânicos..
AR008539A1 (es) PROCESO PARA LA PREPARACIoN DE DERIVADOS DE TIAZOL, INTERMEDIARIOS DEL MISMO Y PROCEDIMENTO PARA LA PREPARACIoN DE INTERMEDIARIOS
BRPI0409069A (pt) compostos quìmicos
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR9909841A (pt) Derivados de pirazolinona, agente de controle de doença das plantas, compostos de pirazolinona, processo para controlar doenças das plantas, e, uso dos derivados de pirazolinona
BR0009453A (pt) Processo para a preparação de um composto
MXPA03008248A (es) Agentes colorantes para fibras de queratina que contienen derivados de n-heteroarilmetil-m-fenilendiamina, asi como nuevos derivados de n-heteroarilmetil-m-fenilendiamina.
ES2191023T3 (es) Procedimiento de preparacion de lodos termales, lodos obtenidos y sus aplicaciones.
ID27440A (id) Proses untuk menyiapkan penengah-penengah
BRPI0415497A (pt) composto processo para a sua preparação , composição farmacêutica que compreende o mesmo, utilização de um composto e método para o tratamento de diabetes do tipo ii
BR9813897A (pt) Derivados de bifenila como farmacêuticos
ATE7700T1 (de) 2-hydroxy-1,2,4-butantricarbonsaeure-oligoribosi - derivate, verfahren zu ihrer herstellung und ihre verwendung als prophylaktische mittel gegen zahnkaries.
BR0000184A (pt) Processo para a preparação de compostos heterocìclicos
DE69943259D1 (de) Neue 2-Halogen-Derivate von 5-O-Desosaminylerythronolid A, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SYNGENTA PARTICIPATIONS AG (CH)

Free format text: TRANSFERIDO DE: NOVARTIS AG (NOVARTIS SA) (NOVARTIS INC.)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/03/2009, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2342 DE 24-11-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.